Ravi Singh to Promoter Regions, Genetic
This is a "connection" page, showing publications Ravi Singh has written about Promoter Regions, Genetic.
Connection Strength
0.214
-
Singh R, Gupta SC, Peng WX, Zhou N, Pochampally R, Atfi A, Watabe K, Lu Z, Mo YY. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis. 2016 06 09; 7(6):e2262.
Score: 0.133
-
Suzuki M, Singh RN, Crystal RG. Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements. Hepatology. 1998 Jan; 27(1):160-5.
Score: 0.037
-
Suzuki M, Singh RN, Crystal RG. Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that raise intracellular levels of cAMP. Hum Gene Ther. 1996 Oct 01; 7(15):1883-93.
Score: 0.034
-
Suzuki M, Singh RN, Crystal RG. Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion. Gene Ther. 1997 Nov; 4(11):1195-201.
Score: 0.009